Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a medication, Clonidine can reduce the
number of days a baby spends in the hospital and the number of days of medical treatment of
withdrawal from Neonatal Abstinence Syndrome (NAS) as compared to Morphine Sulfate (used in
routine care) .